Pharma r&d pipeline and new product launches reach record levels in 2021 according to new iqvia institute for human data science report

Research triangle park, n.c.--(business wire)--biopharmaceutical r&d continued at a record-breaking pace in 2021 despite the covid-19 pandemic, according to a new report, “global trends in r&d – overview through 2021,” by the iqvia institute for human data science. the data show 5,500 new planned clinical trial starts occurred last year, a 14% increase over 2020. also in 2021, new drug approvals and launches accelerated, with 84 novel active substances launched, double the number five y
IQV Ratings Summary
IQV Quant Ranking